Next-generation impactor for the pharmaceutical industry NGI Plus

for aerodynamic particle size distributionfor dry-powder inhalersfor metered-dose inhalers

The Next Generation Impactor NGI+ is perfect for testing nebulizer solutions, especially with biologics. Its enhanced materials withstand corrosive saline mixtures, making it ideal for testing inhalation therapies suited for patients with restricted breathing capacities. Cleaning impactors is crucial for preventing cross-contamination and ensuring consistent results. The NGI+ supports automated, robust cleaning methods using harsher chemicals, saving time and extending the equipment’s life. - Nebulizer testing - Dry powder inhaler (DPI) testing - Metered dose inhaler (MDI) testing - Soft mist inhaler (SMI) testing - Biologics and protein-based drug delivery testing - Corrosive solution testing - Inhalation drug development and research - Design based on the industry proven NGI - Precise cut points - 8-stage collection (7 stage + MOC) - Planar arrangement with cover, cup tray and quick clamp cam - Suite of accessories to make testing even more efficient - Suite of accessories for additional testing (stage bypass, morphological analysis, rNGI) - Enhanced corrosion and chemical resistance - Extended equipment life - Allows for a more robust and/or automated cleaning process for cups, nozzles, and seal body - Comprised of inert materials to maintain aerosol performance - Model Number: 0170-01-2000